User login
Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Emerging Challenges in the Management of HIV and Hepatitis C Virus Coinfection in Veterans
Article PDF
Issue
Federal Practitioner - 25(3)
Publications
Page Number
12
Legacy Keywords
hepatology, HIV, hepatitis C virus, HCV, highly active antiretroviral therapy, HAART, pegylated interferon, ribavirin, inhibitor, inhibitors, protease, PI, PIs, polymerase, nucleoside, nonnucleoside, reverse transcriptase, NRTI, NRTIs, NNRTI, NNRTIs, T cells, CCR5, raltegravir, didanosinehepatology, HIV, hepatitis C virus, HCV, highly active antiretroviral therapy, HAART, pegylated interferon, ribavirin, inhibitor, inhibitors, protease, PI, PIs, polymerase, nucleoside, nonnucleoside, reverse transcriptase, NRTI, NRTIs, NNRTI, NNRTIs, T cells, CCR5, raltegravir, didanosine
Sections
Article PDF
Article PDF
Issue
Federal Practitioner - 25(3)
Issue
Federal Practitioner - 25(3)
Page Number
12
Page Number
12
Publications
Publications
Article Type
Display Headline
Emerging Challenges in the Management of HIV and Hepatitis C Virus Coinfection in Veterans
Display Headline
Emerging Challenges in the Management of HIV and Hepatitis C Virus Coinfection in Veterans
Legacy Keywords
hepatology, HIV, hepatitis C virus, HCV, highly active antiretroviral therapy, HAART, pegylated interferon, ribavirin, inhibitor, inhibitors, protease, PI, PIs, polymerase, nucleoside, nonnucleoside, reverse transcriptase, NRTI, NRTIs, NNRTI, NNRTIs, T cells, CCR5, raltegravir, didanosinehepatology, HIV, hepatitis C virus, HCV, highly active antiretroviral therapy, HAART, pegylated interferon, ribavirin, inhibitor, inhibitors, protease, PI, PIs, polymerase, nucleoside, nonnucleoside, reverse transcriptase, NRTI, NRTIs, NNRTI, NNRTIs, T cells, CCR5, raltegravir, didanosine
Legacy Keywords
hepatology, HIV, hepatitis C virus, HCV, highly active antiretroviral therapy, HAART, pegylated interferon, ribavirin, inhibitor, inhibitors, protease, PI, PIs, polymerase, nucleoside, nonnucleoside, reverse transcriptase, NRTI, NRTIs, NNRTI, NNRTIs, T cells, CCR5, raltegravir, didanosinehepatology, HIV, hepatitis C virus, HCV, highly active antiretroviral therapy, HAART, pegylated interferon, ribavirin, inhibitor, inhibitors, protease, PI, PIs, polymerase, nucleoside, nonnucleoside, reverse transcriptase, NRTI, NRTIs, NNRTI, NNRTIs, T cells, CCR5, raltegravir, didanosine
Sections
Article Source
PURLs Copyright
Inside the Article
Article PDF Media
Document